Biotech investors in San Francisco, United States
Updated 16 Nov 2026
Venture funds
9 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | SOSV SF & NY (Fka IndieBio) SOSV SF & NY, formerly IndieBio, supports deep tech founders, with recent investments including Prolific Machines and heXem bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture | 3% | 14 |
| 2 | Google Ventures Google Ventures provides seed through growth-stage funding to technology companies, with recent investments including Harvey and SambaNova. San Francisco, United States |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 4 |
| 3 | Fifty Years Fifty Years backs entrepreneurs solving the world's biggest problems, recently investing in Multiply Labs and Aalo Atomics. San Francisco, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 19% | 3 |
| 4 | Joyance Partners Joyance Partners invests in companies using science and technology to cultivate joy, with recent investments including Mosh and Sparxell. San Francisco, United States |
Health care, Biotech | Seed, Early stage venture | 8% | 3 |
| 5 | The Column Group The Column Group is a venture firm dedicated to biotechnology companies, with recent companies including Circle Pharma, InduPro and Atavistik Bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 39% | 3 |
| 6 | Artis Ventures Artis Ventures invests in companies at the intersection of technology, health and biology, including Delix Therapeutics and Ozlo Sleep. San Francisco, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 35% | 2 |
| 7 | Builders VC Builders VC invests where technology meets new business models to modernize antiquated industries, including Clay and Pie Systems. San Francisco, United States |
Artificial intelligence, Health care | Early stage venture | 34% | 2 |
| 8 | Dolby Family Ventures Dolby Family Ventures backs early-stage technology companies, with recent investments including Delix Therapeutics, NeuroBionics and Ursa Major. San Francisco, United States |
Hardware, Health care | Seed, Early stage venture, Late stage venture | 7% | 2 |
| 9 | Founders Fund Founders Fund backs companies building new technologies, and recent investments include Nominal and Northwood Space. San Francisco, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 31% | 2 |
Table 1. Biotech investors in San Francisco, United States: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | •••@sosv.com | |
| Right Side Capital Management | Micro VC fund | San Francisco, United States | •••@rightsidecapital.com | +1 415••• |
| AgFunder | Micro VC fund | San Francisco, United States | •••@agfunder.com | |
| General Catalyst | Venture capital firm | San Francisco, United States | •••@generalcatayst.com | +1 415••• |
| Fifty Years | Micro VC fund | San Francisco, United States | •••@fifty.vc | (415) ••• |
| Dolby Family Ventures | Venture capital firm | San Francisco, United States | •••@dolbyventures.com | (415) ••• |
| Cantos | Micro VC fund | San Francisco, United States | •••@cantos.vc | |
| Index Ventures | Venture capital firm | San Francisco, United States | •••@indexventures.com | 415-47••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| SOSV SF & NY (Fka IndieBio) | O••• R••• | Managing General Partner | o•••@sosv.com | In the CSV |
| Right Side Capital Management | D••• L••• | Founder & Managing Director | d•••@rightsidecapital.com | In the CSV |
| AgFunder | R••• L••• P••• | Founding Partner | r•••@agfunder.com | In the CSV |
| General Catalyst | D••• N••• | Managing Director and Member of the Management Committee | d•••@generalcatalyst.com | In the CSV |
| Fifty Years | S••• B••• | Founding Partner | s•••@fiftyyears.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 57 of the 78 biotech investors in San Francisco, United States have a published email address, 41 a phone number and 75 a website.
- SOSV SF & NY (Fka IndieBio) has the most recorded investments, 596, 17 of them as lead investor.
- 61 of them are investors in at least one company that closed its most recent round in the last 12 months.
- General Catalyst is an investor in 38 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Nominal's $240.0M Series C on 9 November 2026.
- Software is the most common sector across their 4,719 portfolio companies (81%).
- Early stage venture is the most common investment stage, recorded for 69 of them (88%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in San Francisco, United States
30 of 78, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | Biotech, Health care | Prolific Machines, heXem bio, BryoSphere | 17 | 596 | 17 | 12 | •••@sosv.com | In the CSV | |
| 2 | Google Ventures | Corporate venture arm, Venture capital firm | San Francisco, United States | Artificial intelligence, Hardware | Snorkel AI, Thatch, Harvey | 20 | 1,331 | 392 | 304 | In the CSV | ||
| 3 | Right Side Capital Management | Micro VC fund, Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Samply, Lincode, Benefitbay | 6 | 2,213 | 65 | 296 | •••@rightsidecapital.com | +1 415••• | In the CSV |
| 4 | AgFunder | Micro VC fund, Venture capital firm | San Francisco, United States | Artificial intelligence, Biotech | OlsAro, CarbonFarm Technology, Amatera | 3 | 154 | 35 | 14 | •••@agfunder.com | In the CSV | |
| 5 | General Catalyst | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Nominal, Tractian, StockGro | 38 | 1,801 | 753 | 271 | •••@generalcatayst.com | +1 415••• | In the CSV |
| 6 | Fifty Years | Micro VC fund, Venture capital firm | San Francisco, United States | Artificial intelligence, Health care | Multiply Labs, Aalo Atomics, Talus Bio | 8 | 179 | 34 | 11 | •••@fifty.vc | (415) ••• | In the CSV |
| 7 | Dolby Family Ventures | Venture capital firm | San Francisco, United States | Hardware, Health care | Delix Therapeutics, NeuroBionics, Ursa Major | 3 | 157 | 11 | 23 | •••@dolbyventures.com | (415) ••• | In the CSV |
| 8 | Cantos | Micro VC fund | San Francisco, United States | Biotech, Health care | SoloPulse, Atom Computing, Prellis Biologics | 3 | 117 | 20 | 11 | •••@cantos.vc | In the CSV | |
| 9 | Civilization Ventures | Venture capital firm | San Francisco, United States | Health care, Biotech | Aikium Inc. | 1 | 72 | 1 | 9 | (888) ••• | In the CSV | |
| 10 | Index Ventures | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Albert Invent, Thatch, Wordsmith AI | 18 | 1,340 | 550 | 293 | •••@indexventures.com | 415-47••• | In the CSV |
| 11 | Liquid 2 Ventures | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Zafrens, Tractian, Mach9 | 26 | 1,243 | 16 | 144 | •••@liquid2.vc | In the CSV | |
| 12 | Founders Fund | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Nominal, Northwood Space, Even Healthcare | 21 | 1,072 | 337 | 188 | +1 415••• | In the CSV | |
| 13 | NFX | Startup accelerator | San Francisco, United States | Artificial intelligence, Fintech | Enso, TwoStep Therapeutics, Remepy | 7 | 495 | 227 | 60 | •••@nfx.com | (408) ••• | In the CSV |
| 14 | Caffeinated Capital | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Antares, Omen AI, Baseten | 8 | 231 | 56 | 29 | (303) ••• | In the CSV | |
| 15 | Foresite Capital | Private equity firm | San Francisco, United States | Health care, Biotech | bit.bio, Thyme Care, Element Biosciences | 5 | 223 | 54 | 95 | •••@foresitecapital.com | +1 415••• | In the CSV |
| 16 | Joyance Partners | Venture capital firm | San Francisco, United States | Health care, Biotech | BioFluff, Mosh, Amatera | 5 | 101 | 8 | 12 | •••@joyancepartners.com | (269) ••• | In the CSV |
| 17 | Alchemist Accelerator | Startup accelerator | San Francisco, United States | Artificial intelligence, Hardware | Kimaru AI, ZaiNar, MoEngage | 4 | 653 | 115 | 69 | •••@alchemistaccelerator.com | (415) ••• | In the CSV |
| 18 | Unpopular Ventures | Syndicate, Venture capital firm | San Francisco, United States | Fintech, Artificial intelligence | Hadrius, Stepful | 2 | 582 | 8 | 33 | In the CSV | ||
| 19 | Abstract | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | Reflex, Standard Metrics, Warp | 13 | 414 | 59 | 43 | In the CSV | ||
| 20 | Biotechnology Value Fund | Venture capital firm | San Francisco, United States | Biotech, Health care | Ambrosia Biosciences | 1 | 188 | 54 | 97 | •••@bvflp.com | (312)5••• | In the CSV |
| 21 | The Column Group | Venture capital firm | San Francisco, United States | Biotech, Health care | Circle Pharma, InduPro, Atavistik Bio | 3 | 137 | 54 | 24 | •••@thecolumngroup.com | (415) ••• | In the CSV |
| 22 | Spark Capital | Venture capital firm | San Francisco, United States | Artificial intelligence, Hardware | Higharc, Sigma Computing, Synera | 10 | 670 | 327 | 126 | •••@sparkcapital.com | 617-83••• | In the CSV |
| 23 | FundersClub | Micro VC fund, Syndicate | San Francisco, United States | Artificial intelligence, Fintech | Numeral, A&K Robotics, Pirros | 5 | 579 | 21 | 122 | •••@fundersclub.com | +1 888••• | In the CSV |
| 24 | TPG | Private equity firm | San Francisco, United States | Fintech, Hardware | Zipline International | 1 | 270 | 125 | 118 | •••@tpg.com | +1 415••• | In the CSV |
| 25 | SV Angel | Venture capital firm | San Francisco, United States | Artificial intelligence, Commerce | Kalshi, Ambient.ai, Rebill | 10 | 1,584 | 35 | 521 | •••@svangel.com | (650) ••• | In the CSV |
| 26 | Soma Capital | Venture capital firm | San Francisco, United States | Fintech, Artificial intelligence | Coframe, Rebill, Aqua | 19 | 1,015 | 21 | 95 | •••@somacap.com | In the CSV | |
| 27 | Social Starts | Micro VC fund, Venture capital firm | San Francisco, United States | Health care, Commerce | Sava Technology | 1 | 473 | 10 | 89 | •••@socialstarts.com | +1 415••• | In the CSV |
| 28 | Asymmetry Ventures | Venture capital firm | San Francisco, United States | Artificial intelligence, Fintech | TYBR Health, Falcomm, ViaBot | 3 | 217 | 3 | 13 | In the CSV | ||
| 29 | Climate Capital | Syndicate, Venture capital firm | San Francisco, United States | Energy, Fintech | CarbonFarm Technology, Terra AI, Colossal Biosciences | 5 | 186 | 2 | 3 | In the CSV | ||
| 30 | Logos Capital | Venture capital firm | San Francisco, United States | Biotech, Health care | Attovia Therapeutics, Elektrofi, Parse Biosciences | 162 | 7 | 109 | •••@logoscapital.com | +1 415••• | In the CSV |
Table 2. Biotech investors in San Francisco, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 78.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | General Catalyst | San Francisco, United States | 38 | 344 | Nominal, Tractian, StockGro |
| 2 | Liquid 2 Ventures | San Francisco, United States | 26 | 313 | Zafrens, Tractian, Mach9 |
| 3 | Founders Fund | San Francisco, United States | 21 | 211 | Nominal, Northwood Space, Even Healthcare |
| 4 | Bessemer Venture Partners | San Francisco, United States | 20 | 293 | Coast, Aghanim, Archy |
| 5 | Google Ventures | San Francisco, United States | 20 | 263 | Snorkel AI, Thatch, Harvey |
| 6 | Soma Capital | San Francisco, United States | 19 | 238 | Coframe, Rebill, Aqua |
| 7 | Index Ventures | San Francisco, United States | 18 | 264 | Albert Invent, Thatch, Wordsmith AI |
| 8 | SOSV SF & NY (Fka IndieBio) | San Francisco, United States | 17 | 57 | Prolific Machines, heXem bio, BryoSphere |
| 9 | Craft Ventures | San Francisco, United States | 14 | 131 | Supabase, GenHealth.ai, Upwind Security |
| 10 | Abstract | San Francisco, United States | 13 | 119 | Reflex, Standard Metrics, Warp |
| 11 | Gradient | San Francisco, United States | 13 | 85 | Infisical, ASI, Labelbox |
| 12 | Quiet Capital | San Francisco, United States | 12 | 131 | Mach9, Thatch, Rundoo |
| 13 | SV Angel | San Francisco, United States | 10 | 350 | Kalshi, Ambient.ai, Rebill |
| 14 | Spark Capital | San Francisco, United States | 10 | 95 | Higharc, Sigma Computing, Synera |
| 15 | XYZ Venture Capital | San Francisco, United States | 9 | 34 | Nominal, ASI, Dust |
Table 3. Biotech investors in San Francisco, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Nominal | Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. | Software | Los Angeles, United States | Series C | $240.0M | 2026-11-09 | $422.5M | General Catalyst, Founders Fund, XYZ Venture Capital | 251 to 500 | 2022 |
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | Dolby Family Ventures, Artis Ventures | 11 to 50 | 2019 |
| Coframe | Coframe builds software that continuously improves websites and apps based on real-world performance data. | Artificial intelligence | San Francisco, United States | Series A | $25.0M | 2026-11-09 | $34.3M | Soma Capital | 11 to 50 | 2023 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | TPG | 1,001 to 5,000 | 2011 |
| bit.bio | Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. | Biotech | Cambridge, United Kingdom | Series D | $25.0M | 2026-11-04 | $250.0M | Foresite Capital | 101 to 250 | 2016 |
| Zafrens | Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. | Biotech | San Diego, United States | Series A | $6.0M | 2026-11-03 | $35.0M | Liquid 2 Ventures | 11 to 50 | 2022 |
| Northwood Space | Northwood Space designs ground infrastructure and deployable systems for spacecraft communication and data handling. | Hardware | Los Angeles, United States | Series C | $375.0M | 2026-11-02 | $536.3M | Founders Fund | 101 to 250 | 2023 |
| Kalshi | Kalshi operates an online prediction market where users trade contracts based on future event outcomes. | Artificial intelligence | New York, United States | Series G | $1.0B | 2026-10-29 | $3.9B | SV Angel | 101 to 250 | 2018 |
| StimCardio | StimCardio develops wearable neuromodulation devices for managing cardiac rhythm disorders. | Health care | Los Angeles, United States | Series A | $30.0M | 2026-10-29 | $32.0M | Particular Ventures | 1 to 10 | 2018 |
| Reflex | Reflex is an open-source Python framework for building and deploying web applications. | Software | San Francisco, United States | Series A | $14.0M | 2026-10-29 | $19.5M | Abstract | 11 to 50 | 2023 |
Table 4. Biotech investors in San Francisco, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 3,829 | 81% |
| Artificial intelligence | 1,289 | 27% |
| Fintech | 867 | 18% |
| Hardware | 708 | 15% |
| Health care | 569 | 12% |
| Commerce | 501 | 11% |
| Cybersecurity | 269 | 6% |
| Biotech | 257 | 5% |
| Education | 167 | 4% |
| Energy | 70 | 1% |
Table 5. Biotech investors in San Francisco, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 69 | 88% |
| Seed investors | 66 | 85% |
| Venture investors | 42 | 54% |
| Late stage investors | 42 | 54% |
| Convertible note investors | 14 | 18% |
| Post IPO investors | 14 | 18% |
| Private equity investors | 13 | 17% |
| Debt investors | 5 | 6% |
Table 6. Biotech investors in San Francisco, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 3 | 4% |
| 2010s | 52 | 71% |
| 2000s | 11 | 15% |
| 1990s | 6 | 8% |
| 1910s | 1 | 1% |
Table 7. Biotech investors in San Francisco, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in San Francisco, United States. On 16 November 2026 that is 78 investors.
- 57 rows carry an email address and 41 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 78 rows: 3 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in San Francisco, United States are on the list?
- 78, in the file dated 16 November 2026. 61 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 57 of the 78 carry an email address in the download and 41 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 78 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 78 rows, 57 firm email addresses and 41 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 40 of the 57 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.